Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Significance of changes in tumor markers in patients trea... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Significance of changes in tumor markers in patients treated with durvalumab plus tremelimumab combination therapy as a surrogate marker for tumor response to unresectable hepatocellular carcinoma
0
Authors
Shinsuke Uchikawa
14 more
Shinsuke Uchikawa
•
Tomokazu Kawaoka
12 more
•
Shiro Oka
Published
August 17, 2024
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Hepatology Research
Topics
Medicine
Cancer Oncology
Internal Medicine
Gastroenterology
Hepatology
Show all topics
DOI
10.1111/hepr.14104
License
CC-BY-NC
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
Hepatology Research
Topics
Medicine
Cancer Oncology
Internal Medicine
Gastroenterology
Hepatology
Show all topics
DOI
10.1111/hepr.14104
License
CC-BY-NC
